- Details
- Description
Packaging Size:
1 × 14 tablets
Strength:
4 mg
Composition:
Pemigatinib INN
Treatment:
Anti-Cancer / Oncology
Form:
Tablet
Brand:
PEMINIB
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
PEMINIB (Pemigatinib INN) is an oral targeted anti-cancer medicine containing pemigatinib, a selective FGFR inhibitor that blocks abnormal fibroblast growth factor receptor signaling involved in cancer growth. It is primarily used for certain advanced or metastatic cholangiocarcinoma with FGFR2 fusion or rearrangement after prior treatment. PEMINIB is listed as an anti-cancer medicine with a 1 × 14-tablet pack.
